Clinical Trials
881 trialsNivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)
Bristol-Myers Squibb
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Incyte Corporation
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
MK-6482-018
Merck Sharp & Dohme LLC
Study of Kidney Tumors in Younger Patients
Children's Oncology Group
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
University of Alabama at Birmingham
EVAX
University Hospital, Bordeaux
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
M.D. Anderson Cancer Center
Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc.
3DPN
University of Leipzig
Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Sun Yat-sen University
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Institut Claudius Regaud
SPARC-1
Columbia University
ZEBRA
Istituto Oncologico Veneto IRCCS
TraveraRTGx
Travera Inc
VICKI
Institut Mutualiste Montsouris
VolUS3D
Assistance Publique - Hôpitaux de Paris
Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers
Novartis
SUP-R
Institut Claudius Regaud
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The Christie NHS Foundation Trust
KIDCaD
Charles University, Czech Republic
Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
MK-4700-001
Merck Sharp & Dohme LLC
CaboPoint
Ipsen
KEYNOTE-564
Merck Sharp & Dohme LLC
ADONIS
Pfizer
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer
EXO-RENAL2
Institute of Oncology Ljubljana
EXO-RENAL1
Institute of Oncology Ljubljana
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
St. Jude Children's Research Hospital
KEYNOTE-426
Merck Sharp & Dohme LLC
A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma
Beth Israel Deaconess Medical Center
OncoCAIX
Philogen S.p.A.
RREIN
University Hospital, Lille
Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
City of Hope Medical Center
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
KEYNOTE-B61
Merck Sharp & Dohme LLC
An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
PIONEER-OPT
Kantonsspital Baden
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
CRISPR Therapeutics
HEMOSTA-PN
Ankara University
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
Coherus Oncology, Inc.
Molecular-Guided Therapy for Childhood Cancer
Milton S. Hershey Medical Center
Study of DF9001 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
MacroGenics
Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Arrowhead Pharmaceuticals
Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC
Goethe University
CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
First Affiliated Hospital of Fujian Medical University
S0931
SWOG Cancer Research Network